| Jeffery Knisley, CRNA | |
|
2220 Canterbury Dr, Hays, KS 67601-2370 | |
| (785) 628-8300 | |
| Not Available |
| Full Name | Jeffery Knisley |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 2220 Canterbury Dr, Hays, Kansas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609325158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 43-557445-121 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Noble Hospital | Kendallville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Colleagues Inc | 8729011333 | 97 |
| Jebs Anesthesia Consultants, Llc | 4486046646 | 30 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
| Entity Name | Clinical Colleagues Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992725766 PECOS PAC ID: 8729011333 Enrollment ID: O20181101000420 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
| Entity Name | Clinical Colleagues Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003469495 PECOS PAC ID: 1850620584 Enrollment ID: O20190905002682 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
| Entity Name | Iceland Anesthesia Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912578667 PECOS PAC ID: 7618372996 Enrollment ID: O20210825000860 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
| Entity Name | Jebs Anesthesia Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790447761 PECOS PAC ID: 4486046646 Enrollment ID: O20220120000233 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery Knisley, CRNA Po Box 821, Hays, KS 67601-0821 Ph: (785) 628-8300 | Jeffery Knisley, CRNA 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: (785) 628-8300 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.
Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.
The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S. Global AIDS Coordinator Eric Goosby's recent address to the Conference on Retroviruses and Opportunistic Infections (CROI) where he reemphasized the Obama administration's commitment to "'maintaining, extending and increasing' the U.S. response to global AIDS." Goosby reflected on the lessons drawn from PEPFAR to date and presented components of the 5-year PEPFAR strategy, the blog notes.
› Verified 6 days ago
Rick Abbott, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3701 Fairway Dr, Hays, KS 67601 Phone: 785-769-4416 | |
Krista Renee Dechant, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-628-8300 | |
Mrs. Taylor David, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 855-429-7633 | |
Jana Bieberle, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 855-429-7633 | |
Ronald E Boyson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1904 E 29th St, Hays, KS 67601 Phone: 785-650-0600 | |
James Gordon Manning Iii, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1904 E 29th Street, Hays, KS 67601 Phone: 785-650-0600 Fax: 785-650-0143 | |
Kari R Ryan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-628-8300 Fax: 785-623-4634 |